1,25-Dihydroxyvitamin D3 inhibits tumor necrosis factor-α-induced adhesion molecule expression in endothelial cells

被引:68
|
作者
Martinesi, M [1 ]
Bruni, S [1 ]
Stio, M [1 ]
Treves, C [1 ]
机构
[1] Univ Florence, Dept Biochem Sci, I-50134 Florence, Italy
关键词
1,25-dihydroxyvitamin D-3; human umbilical vein endothelial cells (HUVEC); tumor necrosis factor-alpha (TNF-alpha); interleukin-1 alpha (IL-1 alpha); adhesion molecules;
D O I
10.1016/j.cellbi.2006.01.004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
This study tested the hypothesis that 1,25-diliydroxyvitamin D-3 [l,25(OH)(2)D-3] plays a role in human umbilical vein endothelial cells (HUVEC) cultures. HUVEC were incubated with 10 or 100 nM 1,25(OH)(2)D-3 for 24 h, in the absence or presence of 40 ng/ml tumor necrosis factor-alpha (TNF-alpha) or 2 ng/ml interleukin-1 alpha (IL-1 alpha). 1,25(OH)(2)D-3 did not affect HUVEC viability and proliferation, while TNF-alpha, alone or in combination with the hormone, significantly inhibited HUVEC viability. [H-3]thymidine incorporation in HUVEC treated with TNF-alpha or IL-1 alpha significantly decreased, in the absence or in the presence of the hormone, while the levels of vitamin D receptor markedly increased in the presence of 1,25(OH)(2)D-3 alone or associated with TNF-alpha or IL-1 alpha, in comparison to the control. The noteworthy increase in protein levels of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) induced by TNF-alpha was significantly decreased after incubation of the cells with 1,25(OH)2D3, this effect not being seen on E-selectin expression. Neither apoptosis nor nuclear translocation of NF-kappa B, induced in HUVEC by TNF-alpha was influenced by 1,25(OH)(2)D-3 treatment. (c) 2006 International Federation for Cell Biology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:365 / 375
页数:11
相关论文
共 50 条
  • [11] 1,25-DIHYDROXYVITAMIN D3 AND THE TESTIS
    WALTERS, MR
    OSMUNDSEN, BC
    CARTER, RM
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 513 : 482 - 484
  • [12] Calcium and 1,25-dihydroxyvitamin D3 regulation of adipokine expression
    Sun, Xiaocun
    Zemel, Michael B.
    OBESITY, 2007, 15 (02) : 340 - 348
  • [13] Stability of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in human serum
    El-Khoury, Joe M.
    Wang, Sihe
    CLINICAL BIOCHEMISTRY, 2012, 45 (09) : 707 - 708
  • [14] Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system
    Veldman, CM
    Cantorna, MT
    DeLuca, HF
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 374 (02) : 334 - 338
  • [15] EXPRESSION OF 1,25-DIHYDROXYVITAMIN D3 RECEPTORS IN PSORIATIC SKIN
    MILDE, P
    HAUSER, U
    RITZ, E
    RAUTERBERG, EW
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 92 (03) : 481 - 481
  • [16] Ginsenoside Rb1 Inhibits Tumor Necrosis Factor-α-Induced Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells
    Chai, Hui
    Wang, Qiuyan
    Huang, Lifeng
    Xie, Tian
    Fu, Yan
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (11) : 2050 - 2056
  • [17] 1,25-Dihydroxyvitamin D3 induces the expression of the tumor suppressor protein CYLD in human leukemia cells
    Vaiou, Maria
    Mosialos, George
    Moulas, Anargyros N.
    JOURNAL OF BIOTECHNOLOGY, 2017, 256 : S29 - S29
  • [18] 1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression
    Li, YJ
    Spataro, BC
    Yang, JW
    Dai, CS
    Liu, YH
    KIDNEY INTERNATIONAL, 2005, 68 (04) : 1500 - 1510
  • [19] Nifedipine inhibits tumor necrosis factor-α-induced leukocyte adhesion to endothelial cells by suppressing vascular cell adhesion molecule-1 (VCAM-1) expression
    Yamagishi, S
    Takeuchi, M
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 2004, 30 (04) : 163 - 168
  • [20] ACTIONS OF 1,25-DIHYDROXYVITAMIN D3 ON HUMAN MESANGIAL CELLS
    WEINREICH, T
    MERKE, J
    SCHONERMARK, M
    REICHEL, H
    DIEBOLD, M
    HANSCH, GM
    RITZ, E
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (03) : 359 - 366